Artwork

Content provided by Medscape Oncology. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Medscape Oncology or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Two 'P' Words Top List of Hot Topics in Breast Cancer

 
Share
 

Archived series ("HTTP Redirect" status)

Replaced by: Medscape Oncology

When? This feed was archived on January 22, 2018 19:33 (6y ago). Last successful fetch was on January 17, 2018 22:48 (6y ago)

Why? HTTP Redirect status. The feed permanently redirected to another series.

What now? If you were subscribed to this series when it was replaced, you will now be subscribed to the replacement series. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.

Manage episode 179997676 series 9914
Content provided by Medscape Oncology. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Medscape Oncology or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Dr Kathy Miller points to PARP inhibitors and pertuzumab as highpoints of the breast cancer program at the upcoming ASCO meeting, including the plenary presentation of the OlympiAD trial.
  continue reading

80 episodes

Artwork
iconShare
 

Archived series ("HTTP Redirect" status)

Replaced by: Medscape Oncology

When? This feed was archived on January 22, 2018 19:33 (6y ago). Last successful fetch was on January 17, 2018 22:48 (6y ago)

Why? HTTP Redirect status. The feed permanently redirected to another series.

What now? If you were subscribed to this series when it was replaced, you will now be subscribed to the replacement series. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.

Manage episode 179997676 series 9914
Content provided by Medscape Oncology. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Medscape Oncology or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Dr Kathy Miller points to PARP inhibitors and pertuzumab as highpoints of the breast cancer program at the upcoming ASCO meeting, including the plenary presentation of the OlympiAD trial.
  continue reading

80 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide